UP in Blended Format for Transdiagnostic Treatment of Emotional Disorders in the Spanish National Health System
Emotional Disorder, Anxiety Disorders, Depressive Disorder
About this trial
This is an interventional treatment trial for Emotional Disorder focused on measuring Emotional Disorder, Unified Protocol, Public health, Transdiagnostic approach
Eligibility Criteria
Inclusion Criteria:
- Principal diagnosis of Emotional disorder (Evaluated by MINI interview)
- The patient is over 18 years of age
- The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
- To have a Smartphone
- Patients taking pharmacological treatment for their ED will be asked to maintain the same dosages and medications for at least 3 months prior to enrolling in the study and during the whole treatment
- The patient signs the informed consent form.
Exclusion Criteria:
- The patient presents a severe condition that would require to be prioritized for treatment, these include a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder), suicide risk at the time of assessment, or substance use in the last three months
- The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable Cognitive behavioral therapy (CBT) principles within the past 5 years.
Sites / Locations
- Hospital Comarcal de VinaròsRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
UP in blended format
Treatment as usual (TAU)
Clinicians will follow the UP therapist manual, 2nd edition, recently translated by Osma and Crespo (13,14). The same contents through a digital material (video and audio) will be integrated in the UP-APP. The program can be developed in a range of 12 to 16 sessions. The UP includes 8 modules
Cognitive Behavioral Therapy in individual format is the treatment of choice (TAU) by psychologists and psychiatrists at the collaborating Public Mental Health Centers and Primary Care Centers, together with pharmacological treatment (i.e., antidepressants and / or anxiolytics).